Search

everythinglearnresearchcommunity

for

Search:↓

Trichloroacetic acid is a safe and effective treatment for hair loss in alopecia areata patients.

Tcf3 helps cells move and heal wounds by controlling lipocalin 2.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Tanshinone IIA helps protect tissue from low oxygen damage by activating certain cell pathways.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

TAF can be identified by excessive skin thickening and clogged hair follicles, helping distinguish it from similar skin conditions.

YAP and TAZ proteins are necessary for the development of two types of skin cancer.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

The study found that Temporal Triangular Alopecia often starts in early childhood, mainly affects the left side of the scalp, and has no effective treatment except surgery.

Combining tacrolimus with excimer light is more effective for treating alopecia areata than using excimer light alone.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

A 3-year-old boy was diagnosed with a rare, non-scarring hair loss condition called temporal triangular alopecia.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

The system allows precise control of gene expression in mouse skin, useful for studying skin biology.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

Tofacitinib shows promise for treating alopecia areata with significant hair regrowth and mild side effects.

Tanshinone IIA helps protect skin tissue from low oxygen damage by boosting certain cell markers.

Some patients on anti-TNF drugs experience a type of hair loss called TAIAPA.

Telocytes in the scalp may help with skin regeneration and maintenance.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.